REGULATED PRESS RELEASE published on 04/30/2026 at 18:00, 5 months 27 days ago LABORATOIRES EUROMEDIS - RAPPORT FINANCIER ANNUEL 2025
BRIEF published on 04/24/2026 at 18:53, 6 months 3 days ago Euromedis Laboratories: 2025 Annual Results Revenue Gross Margin Positive EBITDA 2025 Results Outlook 2026
BRIEF published on 04/24/2026 at 18:53, 6 months 3 days ago Laboratoires Euromedis : Résultats Annuels 2025 Chiffre D'affaires Marge Brute Résultats 2025 Perspectives 2026 EBE Positif
REGULATED PRESS RELEASE published on 04/24/2026 at 18:48, 6 months 3 days ago Laboratoires Euromedis - Communiqué résultat 2025 Publication des résultats annuels 2025 avec une progression de l'activité et de la rentabilité. Perspectives 2026 sous incertitudes liées au contexte géopolitique. Prochains résultats semestriels fin octobre 2026 Résultats Annuels Euronext Growth Progression Incertitudes Perspectives 2026
BRIEF published on 03/26/2026 at 18:05, 7 months 1 day ago Fin du contrat de liquidité pour Laboratoires Euromedis Contrat De Liquidité Euronext Growth Gilbert Dupont Laboratoires Euromedis Simplification Financière
BRIEF published on 03/26/2026 at 18:05, 7 months 1 day ago End of the liquidity contract for Laboratoires Euromedis Liquidity Contract Euronext Growth Gilbert Dupont Euromedis Laboratories Financial Simplification
REGULATED PRESS RELEASE published on 03/26/2026 at 18:00, 7 months 1 day ago LABORATOIRES EUROMEDIS - Fin du contrat de liquidité Laboratoires Euromedis met fin à son contrat de liquidité avec Gilbert Dupont pour les actions cotées sur Euronext Growth, simplifiant ainsi ses opérations financières Contrat De Liquidité Euronext Growth Gilbert Dupont Laboratoires Euromedis Simplification Des Opérations Financières
BRIEF published on 10/31/2025 at 18:09, 11 months 27 days ago Laboratoires Euromedis - Résultats financiers semestriels 2025 Chiffre D'affaires Résultat Net Optimisation Des Coûts Mouvements Sociaux Ventes À L'export
BRIEF published on 10/31/2025 at 18:09, 11 months 27 days ago Euromedis Laboratories - 2025 Half-Year Financial Results Revenue Net Result Cost Optimization Export Sales Social Movements
REGULATED PRESS RELEASE published on 10/31/2025 at 18:04, 11 months 27 days ago LABORATOIRES EUROMEDIS - RAPPORT FINANCIER SEMESTRIEL 2025 SA Laboratoires Euromedis publie son rapport financier semestriel au 30 juin 2025, montrant une progression du chiffre d'affaires de 11% et un retour au positif du résultat net Chiffre D'affaires Rapport Financier Résultat Net SA Laboratoires Euromedis 30 Juin 2025
Published on 10/27/2026 at 23:25, 49 minutes ago Gamma Resources Announces Leadership Transition: C. Connor Messler to Become Chief Executive Officer and Gabriel Alonso-Mendoza to Become Chairman; Grants Incentive Stock Options
Published on 10/27/2026 at 21:30, 2 hours 44 minutes ago Apex Announces Closing of Over-Allotment Option
Published on 10/27/2026 at 21:15, 2 hours 59 minutes ago Goldcliff Closes First Tranche of Private PLacement
Published on 10/27/2026 at 21:10, 3 hours 4 minutes ago International Battery Metals Announces Leadership Transition
Published on 10/27/2026 at 22:40, 1 hour 33 minutes ago EQS-Adhoc: NEXTDC Limited: Financial Covenants - Compliance and Headroom
Published on 10/27/2026 at 22:30, 1 hour 44 minutes ago Tensor and Münchner Taxi Zentrum Sign LOI to Put Taxi Operators at the Center of Autonomous Mobility in Germany
Published on 10/27/2026 at 20:35, 3 hours 39 minutes ago Piramal Pharma Limited Announces Results for Q2 and H1 FY27
Published on 10/27/2026 at 19:17, 4 hours 56 minutes ago ZF Finance GmbH : Indicative Maximum Acceptance Amount in relation to the Tender Offer.
Published on 10/27/2026 at 18:00, 6 hours 14 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 22, 2026
Published on 10/27/2026 at 18:00, 6 hours 14 minutes ago Nombre total de droits de vote et actions composant le capital social au 22 octobre 2026
